|
84 Companies |
|
113 Products |
|
113 Products |
|
110 Mechanisms of Action |
|
3 Trials |
|
2476 News |
|
| 12345678910111213...4950» |
- | Enrollment change, Intubation: ECLAIR: Extracorporeal Lung Assist to Avoid Intubation in Patients Failing Noninvasive Ventilation for Hypercapnic ARF (clinicaltrials.gov) - Aug 9, 2024
P=N/A, N=50, Completed, Sponsor: Universit
N=30 --> 50
- | Trial termination: Hantavirus Transmission in Households in Chile (clinicaltrials.gov) - Jan 11, 2024
P=N/A, N=197, Terminated, Sponsor: University of New Mexico
N=30 --> 50 Completed --> Terminated; This is not a clinical trial and was inadvertently added to the system.
- | Enrollment change, Trial withdrawal: Non-Inferiority Trial of Acute HFT Versus nCPAP (clinicaltrials.gov) - May 3, 2023
P=N/A, N=0, Withdrawn, Sponsor: Vapotherm, Inc.
Completed --> Terminated; This is not a clinical trial and was inadvertently added to the system. N=56 --> 0 | Completed --> Withdrawn
- | Trial completion: RCT ATE/ATT: ATT Compared With ATE in OSAS Children (clinicaltrials.gov) - Mar 10, 2023
P=N/A, N=79, Completed, Sponsor: Karolinska University Hospital
N=56 --> 0 | Completed --> Withdrawn Unknown status --> Completed
- | Trial completion date, Trial primary completion date: In-Hospital Portable Sleep Monitoring for the Evaluation of Obstructive Sleep Apnea (OSA) (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=140, Active, not recruiting, Sponsor: John H. Stroger Hospital
Unknown status --> Completed Trial completion date: Mar 2016 --> Dec 2024 | Trial primary completion date: Feb 2015 --> Jun 2022
- | Enrollment change: Using Continuous Positive Airway Pressure to Reduce the Incidence of Acute Kidney Injury in Hospitalized Patients With Chronic Kidney Disease (clinicaltrials.gov) - Apr 29, 2019
P=N/A, N=0, Withdrawn, Sponsor: University of South Florida
Trial completion date: Mar 2016 --> Dec 2024 | Trial primary completion date: Feb 2015 --> Jun 2022 N=125 --> 0
- || Enrollment change: Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=44, Completed, Sponsor: Philips Respironics
N=125 --> 0 N=20 --> 44
- | Trial completion: Morphee: Down Syndrome and Continuous Positive Pressure Therapy (clinicaltrials.gov) - Apr 21, 2019
P=N/A, N=31, Completed, Sponsor: Institut Jerome Lejeune
N=20 --> 44 Recruiting --> Completed
- ||||||| Trial completion, Enrollment change, Monotherapy, Head-to-Head: Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment (clinicaltrials.gov) - Apr 20, 2019
P3, N=260, Completed, Sponsor: EMS
Recruiting --> Completed Recruiting --> Completed | N=120 --> 260
- | Trial completion, Trial completion date, Trial primary completion date: Exploring the Role of Adipocyte Fatty Acid Binding Protein in the Association of Obstructive Sleep Apnea and Metabolic Dysfunction (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=90, Completed, Sponsor: The University of Hong Kong
Recruiting --> Completed | N=120 --> 260 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018
- | betamethasone / Generic mfg.
Trial completion, Trial completion date: Betamethasone and Severity of Hyaline Membrane Disease (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=127, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018
- ||| Trial completion, Enrollment change: Investigative Headgear With CPAP Mask (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=23, Completed, Sponsor: Fisher and Paykel Healthcare
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018 Enrolling by invitation --> Completed | N=300 --> 23
- | Trial completion: MATRICS: Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=121, Completed, Sponsor: Northwestern University
Enrolling by invitation --> Completed | N=300 --> 23 Active, not recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: SOMMEDREP: Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children (clinicaltrials.gov) - Mar 14, 2019
P=N/A, N=62, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Aug 2018 | Trial primary completion date: Jan 2019 --> Aug 2018
- | aspirin / Generic mfg.
Trial completion date, Trial termination, Trial primary completion date: ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial (clinicaltrials.gov) - Mar 13, 2019
P2, N=49, Terminated, Sponsor: Belfast Health and Social Care Trust
Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Aug 2018 | Trial primary completion date: Jan 2019 --> Aug 2018 Trial completion date: Jul 2017 --> Nov 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Jul 2017 --> Nov 2018; Slow recruitment
- | midazolam hydrochloride / Generic mfg.
Trial completion: Pilot Study on Pairing Sedation Strategies and Weaning (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=90, Completed, Sponsor: MemorialCare Health System
Trial completion date: Jul 2017 --> Nov 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Jul 2017 --> Nov 2018; Slow recruitment Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date, Surgery: Randomized Control Trials of Surgery for Pediatric OSA (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=143, Completed, Sponsor: Karolinska University Hospital
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Oct 2026 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019
- | Trial completion, Trial completion date: The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome (clinicaltrials.gov) - Feb 28, 2019
P=N/A, N=160, Completed, Sponsor: Indiana University
Active, not recruiting --> Completed | Trial completion date: Oct 2026 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2017
- | dexamethasone injection / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: DEXA-ARDS: Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Feb 18, 2019
P4, N=277, Completed, Sponsor: Dr. Negrin University Hospital
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2017 Recruiting --> Completed | Trial completion date: Oct 2018 --> Feb 2019 | Trial primary completion date: Oct 2018 --> Feb 2019
- | Gastrocrom (cromolyn) / Viatris
Trial termination: Cromolyn Detection of Silent Aspiration (clinicaltrials.gov) - Feb 16, 2019
P1, N=16, Terminated, Sponsor: University of California, San Francisco
Recruiting --> Completed | Trial completion date: Oct 2018 --> Feb 2019 | Trial primary completion date: Oct 2018 --> Feb 2019 Recruiting --> Terminated; Difficulty recruiting; Funding ended; interim analysis provided sufficient data for interpretation.
- | Trial completion, Trial completion date, Trial primary completion date: Fluid Shift on Obstructive and Central Sleep Apnea (clinicaltrials.gov) - Feb 12, 2019
P=N/A, N=36, Completed, Sponsor: Nanjing Medical University
Recruiting --> Terminated; Difficulty recruiting; Funding ended; interim analysis provided sufficient data for interpretation. Recruiting --> Completed | Trial completion date: Jun 2018 --> Feb 2019 | Trial primary completion date: Jun 2018 --> Dec 2018
- | Enrollment change, Trial withdrawal: Autologous Umbilical Cord Blood Transfusion for Preterm Neonates (clinicaltrials.gov) - Feb 12, 2019
P1, N=0, Withdrawn, Sponsor: Sahar M.A. Hassanein, MD
Recruiting --> Completed | Trial completion date: Jun 2018 --> Feb 2019 | Trial primary completion date: Jun 2018 --> Dec 2018 N=60 --> 0 | Recruiting --> Withdrawn
- ||| Trial completion: Efficacy and Physiology of Nasal High Flow Therapy (clinicaltrials.gov) - Feb 11, 2019
P=N/A, N=46, Completed, Sponsor: Institut für Pneumologie Hagen Ambrock eV
N=60 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed
- | Trial completion, Enrollment change: The Effects of Airtrapping on Sleep and Breathing in Non Invasive Ventilation (NIV) in COPD (clinicaltrials.gov) - Feb 11, 2019
P=N/A, N=10, Completed, Sponsor: Institut f
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=15 --> 10
- | Enrollment change: Proprioceptive Postural Control and Diaphragm Paresis (clinicaltrials.gov) - Feb 8, 2019
P=N/A, N=0, Withdrawn, Sponsor: KU Leuven
Active, not recruiting --> Completed | N=15 --> 10 N=20 --> 0
- ||| Trial completion, Trial primary completion date: Evaluation of Cardiopulmonary Diseases by Ultrasound (clinicaltrials.gov) - Feb 8, 2019
P=N/A, N=600, Completed, Sponsor: Echosense Ltd.
N=20 --> 0 Recruiting --> Completed | Trial primary completion date: Dec 2018 --> May 2018
- | Phase classification, Enrollment change: Mild Cognitive Impairment and Obstructive Sleep Apnea (clinicaltrials.gov) - Jan 29, 2019
P=N/A, N=54, Completed, Sponsor: George Mason University
Recruiting --> Completed | Trial primary completion date: Dec 2018 --> May 2018 Phase classification: P3 --> P=N/A | N=86 --> 54
- ||||| Naphcon-A (naphazoline HCl) / Novartis, Alervil (pheniramine maleate) / Incepta
Enrollment change: Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal (clinicaltrials.gov) - Jan 25, 2019
P3, N=132, Completed, Sponsor: EMS
Phase classification: P3 --> P=N/A | N=86 --> 54 N=212 --> 132
- | aspirin / Generic mfg.
Trial completion: High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD) (clinicaltrials.gov) - Jan 17, 2019
P=N/A, N=10, Completed, Sponsor: Brigham and Women's Hospital
N=212 --> 132 Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: SAMSPAP: Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial (clinicaltrials.gov) - Jan 12, 2019
P=N/A, N=49, Completed, Sponsor: McGill University
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Mar 2019 --> Nov 2018 | Trial primary completion date: Sep 2018 --> Nov 2018
- | valsartan / Generic mfg.
Trial completion date, Trial termination: Intermittent Hypoxia 2: Cardiovascular and Metabolism (clinicaltrials.gov) - Dec 31, 2018
P4, N=12, Terminated, Sponsor: University Hospital, Grenoble
Recruiting --> Completed | Trial completion date: Mar 2019 --> Nov 2018 | Trial primary completion date: Sep 2018 --> Nov 2018 Trial completion date: Dec 2017 --> Mar 2017 | Active, not recruiting --> Terminated; budget constraints
- | Trial completion date, Trial primary completion date: SOMMEDREP: Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children (clinicaltrials.gov) - Dec 22, 2018
P=N/A, N=62, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial completion date: Dec 2017 --> Mar 2017 | Active, not recruiting --> Terminated; budget constraints Trial completion date: Aug 2018 --> Jan 2019 | Trial primary completion date: Aug 2018 --> Jan 2019
- | Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury (clinicaltrials.gov) - Dec 20, 2018
P1, N=13, Terminated, Sponsor: Denver Health and Hospital Authority
Trial completion date: Aug 2018 --> Jan 2019 | Trial primary completion date: Aug 2018 --> Jan 2019 N=20 --> 13 | Trial completion date: May 2021 --> Nov 2018 | Recruiting --> Terminated | Trial primary completion date: May 2021 --> Nov 2018; low enrollment and loss of funding
- | Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Lung and Systemic Inflammation in the Critically Ill Patient (clinicaltrials.gov) - Dec 12, 2018
P=N/A, N=8, Terminated, Sponsor: Rigshospitalet, Denmark
N=20 --> 13 | Trial completion date: May 2021 --> Nov 2018 | Recruiting --> Terminated | Trial primary completion date: May 2021 --> Nov 2018; low enrollment and loss of funding N=18 --> 8 | Trial completion date: Nov 2017 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Dec 2018; Slow enrollment and therefore not possible to reach the estimated enrollment
- | Enrollment change, Trial completion date, Trial primary completion date: Bi-Level Positive Airway Ventilation for Acute Chest Syndrome (clinicaltrials.gov) - Dec 12, 2018
P=N/A, N=3, Terminated, Sponsor: Albert Einstein College of Medicine, Inc.
N=18 --> 8 | Trial completion date: Nov 2017 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Dec 2018; Slow enrollment and therefore not possible to reach the estimated enrollment N=60 --> 3 | Trial completion date: Jul 2014 --> Sep 2016 | Trial primary completion date: Jul 2014 --> Sep 2016
- Enrollment change: Obesity Hypoventilation Syndrome Prevalence Study (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=44, Terminated, Sponsor: Philips Respironics
N=60 --> 3 | Trial completion date: Jul 2014 --> Sep 2016 | Trial primary completion date: Jul 2014 --> Sep 2016 N=200 --> 44
- ||| Trial completion, Trial completion date: NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=32, Completed, Sponsor: Medical University of South Carolina
N=200 --> 44 Active, not recruiting --> Completed | Trial completion date: Apr 2017 --> Jul 2017
- | lansoprazole / Generic mfg.
Enrollment change, Trial withdrawal: Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea (clinicaltrials.gov) - Dec 10, 2018
P=N/A, N=0, Withdrawn, Sponsor: MetroHealth Medical Center
Active, not recruiting --> Completed | Trial completion date: Apr 2017 --> Jul 2017 N=50 --> 0 | Terminated --> Withdrawn
- | montelukast / Generic mfg.
Trial completion: Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA) (clinicaltrials.gov) - Dec 3, 2018
P3, N=34, Completed, Sponsor: Romaker & Associates
N=50 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Completed
- | Trial termination: PHARLAP: A Multi-centre Trial of an Open Lung Strategy Including Permissive Hypercapnia, Alveolar Recruitment and Low Airway Pressure in Patients With Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Nov 28, 2018
P=N/A, N=115, Terminated, Sponsor: Australian and New Zealand Intensive Care Research Centre
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Halted by the Management Committee after the publication of the ART Trial
- | Enrollment change: Cycling of Sedative Infusions in Critically Ill Pediatric Patients (clinicaltrials.gov) - Nov 23, 2018
P=N/A, N=25, Terminated, Sponsor: Javier Gelvez, MD
Active, not recruiting --> Terminated; Halted by the Management Committee after the publication of the ART Trial N=120 --> 25
- | Trial primary completion date: Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury (clinicaltrials.gov) - Nov 21, 2018
P=N/A, N=204, Completed, Sponsor: Beijing Hospital
N=120 --> 25 Trial primary completion date: Jun 2013 --> Dec 2016
- | Enrollment change, Trial primary completion date: Noninvasive Positive Pressure Ventilation in Moderate Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Nov 21, 2018
P=N/A, N=120, Completed, Sponsor: Beijing Hospital
Trial primary completion date: Jun 2013 --> Dec 2016 N=200 --> 120 | Trial primary completion date: Jul 2013 --> Dec 2016
- | Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Anti-MERS-CoV Convalescent Plasma Therapy (clinicaltrials.gov) - Nov 21, 2018
P2, N=0, Withdrawn, Sponsor: King Abdullah International Medical Research Center
N=200 --> 120 | Trial primary completion date: Jul 2013 --> Dec 2016 N=20 --> 0 | Trial completion date: Jun 2017 --> Nov 2016 | Active, not recruiting --> Withdrawn | Trial primary completion date: May 2017 --> May 2016
- | Trial completion, Trial completion date, Trial primary completion date: Impact of CPAP Therapy in Obstructive Sleep Apnea on Parameters of Nocturnal Pulse Wave Analysis (clinicaltrials.gov) - Oct 30, 2018
P=N/A, N=314, Completed, Sponsor: Wissenschaftliches Institut Bethanien e.V
N=20 --> 0 | Trial completion date: Jun 2017 --> Nov 2016 | Active, not recruiting --> Withdrawn | Trial primary completion date: May 2017 --> May 2016 Recruiting --> Completed | Trial completion date: Dec 2017 --> May 2017 | Trial primary completion date: Dec 2017 --> May 2017
- | Trial completion, Phase classification, Trial completion date, Trial primary completion date: ISAACC: Continuous Positive Airway Pressure (CPAP) in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea (OSA) (clinicaltrials.gov) - Oct 18, 2018
P=N/A, N=1864, Completed, Sponsor: Sociedad Española de Neumología y Cirugía Torácica
Recruiting --> Completed | Trial completion date: Dec 2017 --> May 2017 | Trial primary completion date: Dec 2017 --> May 2017 Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Sep 2017 --> Sep 2018
- | Enrollment change: STANDARDS: Stratification of the Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Oct 13, 2018
P=N/A, N=300, Completed, Sponsor: Dr. Negrin University Hospital
Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Sep 2017 --> Sep 2018 N=600 --> 300
- | aspirin / Generic mfg.
Enrollment change, Trial termination: Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients (clinicaltrials.gov) - Oct 12, 2018
P=N/A, N=53, Terminated, Sponsor: University Hospital, Grenoble
N=600 --> 300 N=286 --> 53 | Recruiting --> Terminated; Recommendations changing
- | ketamine / Generic mfg.
Enrollment change, Trial withdrawal: Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect? (clinicaltrials.gov) - Oct 3, 2018
P=N/A, N=0, Withdrawn, Sponsor: Western Galilee Hospital-Nahariya
N=286 --> 53 | Recruiting --> Terminated; Recommendations changing N=50 --> 0 | Recruiting --> Withdrawn
- | Trial completion, Enrollment change: FOCIS: Frequency of Oral Care Intervention Study (clinicaltrials.gov) - Sep 21, 2018
P=N/A, N=232, Completed, Sponsor: University of South Florida
N=50 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | N=345 --> 232